Jifeng Ventures

Jifeng Ventures is a Shanghai-based boutique fund focused on early-stage life sciences and biomedical innovation. Operating from one of China’s primary biotech hubs, the firm participates in biotech and medical device deals where novel therapeutics, platform biology, and clinical-grade hardware are advancing from research into early commercial development. Jifeng has cultivated a reputation as a focused, science-driven investor, though detailed information about fund size, named partners, and full portfolio remains limited in public English-language sources.

The firm invests across Seed, Series A, and Series B rounds, with checks typically in the one to five million dollar range. Investment activity is concentrated in China, with Shanghai’s deep clinical research, hospital, and academic infrastructure providing natural deal flow. Founders building therapeutic, diagnostic, or device platforms that require domain-knowledgeable early capital are the kind of company the firm appears positioned to support, particularly those operating in zones like Zhangjiang and other Shanghai biomedical clusters.

The boutique structure suggests a partner-led engagement model where founders work closely with a small senior team rather than a layered platform organization. Limited public information about specific board engagement practices, follow-on philosophy, and decision timing means founders should rely on portfolio references and direct conversation to assess fit. The firm appears best suited as a local lead or co-investor for science-driven healthcare companies that benefit from a Shanghai-anchored institutional partner with life sciences fluency, particularly when bridging from preclinical or prototype work into early clinical or regulatory milestones.